These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
584 related items for PubMed ID: 19720564
1. Reporter genes facilitating discovery of drugs targeting protozoan parasites. Dube A, Gupta R, Singh N. Trends Parasitol; 2009 Sep; 25(9):432-9. PubMed ID: 19720564 [Abstract] [Full Text] [Related]
2. Fluorescent Leishmania species: development of stable GFP expression and its application for in vitro and in vivo studies. Bolhassani A, Taheri T, Taslimi Y, Zamanilui S, Zahedifard F, Seyed N, Torkashvand F, Vaziri B, Rafati S. Exp Parasitol; 2011 Mar; 127(3):637-45. PubMed ID: 21187086 [Abstract] [Full Text] [Related]
3. Advances and perspectives in Leishmania cell based drug-screening procedures. Sereno D, Cordeiro da Silva A, Mathieu-Daude F, Ouaissi A. Parasitol Int; 2007 Mar; 56(1):3-7. PubMed ID: 17079188 [Abstract] [Full Text] [Related]
5. [Source and significance of genetic polymorphism of selected parasitic protozoa]. Majewska AC, Sulima P. Wiad Parazytol; 1999 Mar; 45(3):293-307. PubMed ID: 16886368 [Abstract] [Full Text] [Related]
6. Improvement of the green fluorescent protein reporter system in Leishmania spp. for the in vitro and in vivo screening of antileishmanial drugs. Pulido SA, Muñoz DL, Restrepo AM, Mesa CV, Alzate JF, Vélez ID, Robledo SM. Acta Trop; 2012 Apr; 122(1):36-45. PubMed ID: 22155571 [Abstract] [Full Text] [Related]
7. Evasion of innate immunity by parasitic protozoa. Sacks D, Sher A. Nat Immunol; 2002 Nov; 3(11):1041-7. PubMed ID: 12407413 [Abstract] [Full Text] [Related]
12. Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening. Singh N, Gupta R, Jaiswal AK, Sundar S, Dube A. J Antimicrob Chemother; 2009 Aug; 64(2):370-4. PubMed ID: 19525291 [Abstract] [Full Text] [Related]
13. Potent antiprotozoal activity of a novel semi-synthetic berberine derivative. Bahar M, Deng Y, Zhu X, He S, Pandharkar T, Drew ME, Navarro-Vázquez A, Anklin C, Gil RR, Doskotch RW, Werbovetz KA, Kinghorn AD. Bioorg Med Chem Lett; 2011 May 01; 21(9):2606-10. PubMed ID: 21474310 [Abstract] [Full Text] [Related]
14. [Target points of antiparasitic drugs]. Boczoń K. Wiad Parazytol; 1988 May 01; 34(4-6):529-43. PubMed ID: 3071915 [No Abstract] [Full Text] [Related]